Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anna Goździk is active.

Publication


Featured researches published by Anna Goździk.


Polish archives of internal medicine | 2018

Dilatation of aortic root in patients after kidney transplantation

Marta Obremska; M. Boratyńska; Maciej Szymczak; Dorota Zyśko; Tomasz Płonek; Anna Goździk; Marian Klinger

INTRODUCTION Aortic root (AoR) dilation is associated with cardiac damage and higher cardiovascular risk. Cardiovascular disease is the most common cause of death in patients after kidney transplantation (KTx ). OBJECTIVES The aim of this study was to assess the prevalence of enlarged AoR diameter in KTx recipients. Patients with bicuspid aortic valve, significant valvular disease, or evidence of connective tissue disorder were excluded. PATIENTS AND METHODS A total of 87 KTx recipients were divided into 2 groups depending on immunosuppressive regimen: 41 patients receiving mammalian target of rapamycin inhibitors (mTORi) and 46 patients treated with calcineurin inhibitors (CNIs). In all patients, echocardiography was performed, laboratory and clinical markers of cardiovascular risk were assessed, and the AoR diameter was calculated. RESULTS There were no differences between groups in age, sex, body surface area, body mass index, frequency of diabetes, hypertension, dyslipidemia, time after replacement therapy, creatinine levels, and estimated glomerular filtration rate. In the CNI group, the observed and calculated AoR diameters were similar (P = 0.8). In the mTORi group, the observed AoR diameter was higher than the calculated one (P = 0.002). The concentric and eccentric left ventricular hypertrophy was similar in both groups (P = 0.12 and P = 0.69, respectively). In the stepwise regression analysis, the AoR diameter was associated with body surface area and mTORi treatment. CONCLUSIONS KTx recipients have a high prevalence of AoR dilation. Immunosuppressive regimen based on mTORi increases the incidence of AoR enlargement.


Folia Cardiologica | 2017

Śluzak lewej komory serca powikłany zatorowością obwodową

Dariusz Dąbrowski; Anna Goździk; Aleksandra Milnerowicz; Jacek Jakubaszko; Waldemar Goździk; Wojciech Kosmala

Left ventricular myxoma is a very rare, benign primary cardiac tumor. Due to its localization, size and mobility, it may be a source of peripheral embolism. The recurrence of myxoma after surgical removal is rare, ranging from 0% to 3% in solitary tumors and 12–22% in the familial type. We report two cases of left ventricular myxomas complicated by arterial embolism. In the first case of a 19-years old male, apart from systemic embolisation, a very fast tumor growth, suggesting thrombus formation, was observed. In the second case of a 42-years old male, the recurrence of myxoma in left ventricle apex was found 2 months after surgical excision, together with de novo development of two additional tumors in the right atrium. Clinical features of cardiac myxoma, both in terms of complications and recurrences, necessitate careful follow up with an echocardiographic control in all patients after tumor removal surgery.


Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery | 2015

Long-term efficacy of surgical ablation of atrial fibrillation in a low-volume centre

Maciej Rachwalik; Dorota Zyśko; Grzegorz Bielicki; Marta Obremska; Anna Goździk; Wojciech Kustrzycki

Surgical ablation is a recommended procedure for patients with atrial fibrillation (AF) undergoing a cardiac surgery operation. However, the procedure is associated with significant risk of late recurrence of AF. The aim of the study was to assess the long-term efficacy of the procedure with respect to the comorbidities. The study group consisted of 22 patients: 9 women and 13 men, who underwent surgical AF ablation in the 2008-2013 period. The patients were interviewed by telephone and were asked to send their recently performed 12-lead electrocardiography (ECG). The semi-structured interview consisted of 25 items regarding the history of AF, concomitant comorbidities, lifelong syncopal history, smoking, family history of premature cardiovascular diseases, and current medical treatment. Furthermore, the Epworth test was performed to measure the daytime sleepiness, which in turn is related to the presence of obstructive sleep apnoea. On the basis of the obtained data, the CHADS2, and Epworth scale scores were calculated for each patient. As a result of the study six patients (27%) had sinus rhythm or paced dual chamber rhythm, and 16 patients had atrial fibrillation. The multivariate analysis revealed that Epworth scale scoring > 9, CHADS2 score > 0, and persistent type of AF were related to poor outcome of surgical ablation procedure. In conclusion, patients with AF treated with surgical ablation have similar prognosis of sinus rhythm maintenance to those treated with radiofrequency ablation. Moreover, the same predisposing factors play a significant role in AF recurrence both in surgical patients and in patients treated with radiofrequency ablation.


Advances in Clinical and Experimental Medicine | 2015

Does the Stage of Chronic Kidney Failure Influence the Outcome in Cardiac Surgery

Anna Goździk; Jacek Jakubaszko; Tomasz Grzebieniak; Wojciech Kustrzycki; Waldemar Goździk

BACKGROUND The number of patients with chronic kidney failure requiring cardiac surgery is continuously increasing. Additionally, significant worsening in the overall risk profile of this group of patients is noted. OBJECTIVES To investigate the effect of chronic renal dysfunction both in non-dialysis-dependent renal failure and end-stage renal failure patients, on early mortality--morbidity and late survival in a series of cardiac surgery patients at our institution. MATERIAL AND METHODS 1344 patients who had open heart surgery at our university hospital between 2010 and 2013 were retrospectively reviewed. Chronic renal dysfunction was defined according to preoperative glomerular filtration rate. Patients selection (n=80). Group 1 mild--(GRF 59-30 mL/min), Group 2 moderate--(GFR 29-15 mL/min), Group 3 end stage--(GFR<15 mL/min) renal failure. RESULTS Chronic renal dysfunction was present in 5.95% of all patients studied. Group 1--55 (68.75%), Group 2--16 (20%), Group 3--9 (11.25%). No difference between the groups in the need for heart inotropic support was noted; however the use of these medications was necessary in 60.6% of all studied patients. Forty nine percent in Group 1, 87.5% in Group 2 and 77% in Group 3, respectively. Renal replacement therapy in the early postoperative period was needed in 12 patients, with significance between the groups (p = 0.001). The overall hospital mortality was 2.5%. Follow-up was completed with a mean of 1.4 years (range 2 months to 4 years). There were 6 (7.5%) late deaths. CONCLUSIONS Our observations do not exhibit large variations in postoperative complications and deaths in patients with chronic renal failure, depending on the degree of preoperative renal function impairment. It seems that renal failure regardless of the degree of impairment is a factor aggravating the intra and post-operative course in cardiac surgery patients.


Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine | 2016

Beneficial effect of bilateral native nephrectomy as complete denervation on left ventricular mass and function in renal transplant recipients.

Marta Obremska; M. Boratyńska; Dorota Zyśko; Maciej Szymczak; Jacek Kurcz; Anna Goździk; Maciej Rachwalik; Marian Klinger


Kardiologia Polska | 2006

Case reports Myocardial bridging of the left anterior descending coronary artery and dobutamine-induced left ventricular outflow tract gradient – a case report

Wiktor Kuliczkowski; Anna Goździk; Marcin Protasiewicz; Marta Negrusz-Kawecka; Walentyna Mazurek


Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery | 2012

ANESTEZJOLOGIA I INTENSYWNA TERAPIA Inhaled nitric oxide effects outside the lungs – experimental and clinical evidence

Waldemar Goździk; Anna Goździk


Kardiologia Polska | 2004

[A giant left atrial myxoma as a cause of a low cardiac output syndrome: a case report].

Marek Pelczar; Anna Goździk; Arkadiusz Derkacz; Małgorzata Lipińska-Gediga; Wojciech Kustrzycki


Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery | 2012

ANESTEZJOLOGIA I INTENSYWNA TERAPIA Inhaled nitric oxide effects outside the lungs – proven and possible mechanisms

Waldemar Goździk; Anna Goździk


Medical Science and Technology | 2010

Cardiac Myxoma: 10 Years’ experience in 29 Patients operated with crystalloid cardioplegia – early and mid long term results

Maciej Rachwalik; Marta Obremska; Anna Goździk

Collaboration


Dive into the Anna Goździk's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marta Obremska

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Waldemar Goździk

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Maciej Rachwalik

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Robert Skalik

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Dorota Zyśko

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Andrzej Kübler

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Grzegorz Bielicki

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

M. Boratyńska

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar

Maciej Szymczak

Wrocław Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge